New therapy aims to ease grief after miscarriage or stillbirth

NCT ID NCT07538011

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This pilot study tests a 4-week program based on acceptance and commitment therapy (ACT) for women who have experienced a miscarriage, stillbirth, or newborn death within the past year. The program includes six sessions plus a booster, combining in-person and video meetings. Researchers will measure whether it reduces grief, depression, and anxiety, and if it's practical and acceptable for participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Acceptance and Commitment Therapy (ACT) - a type of talk therapy
What this could lead to
If it works, this could offer a new, practical way to help women cope with grief and mental health struggles after losing a pregnancy or newborn.
What could go wrong
This is a very small pilot study with only 88 people, so results may not apply widely. It's testing feasibility, not proven effectiveness, and success is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Second Xiangya Hospital, Central South University

    Changsha, Hunan, 410000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.